Big Pharma | |
---|---|
![]() | |
Developer(s) | Twice Circled |
Publisher(s) | Positech Games Klabater (console) |
Designer(s) | Tim Wicksteed [1] [2] |
Engine | Unity |
Platform(s) | Microsoft Windows, OS X, Linux, Xbox One, Nintendo Switch, PlayStation 4 |
Release | Microsoft Windows, OS X, Linux
|
Genre(s) | Puzzle game, construction and management simulation |
Mode(s) | Single-player |
Big Pharma is a simulation game developed by Twice Circled and published by Positech Games where the player builds a drug factory. [3] The game was released on August 27, 2015.
In Big Pharma the player takes the role as the manager of a pharmaceutical company, producing medication from raw materials. Raw materials have intrinsic positive (e.g., "Reduces coughs") and negative (e.g., "Induces drowsiness") effects that present themselves when the material is within a set concentration range, with possible concentrations ranging on a 0-to-20 scale. Most of the positive benefits can be enhanced to more desirable effects, or negative side effects can be outright removed, by bringing the material to a specific concentration range and applying an indicated process, some further requiring the addition of a catalyst material which itself carries positive and negative effects. Materials can also be mixed to combine positive and negative benefits to create more potent drugs. The goal in the mixing and preparation of materials is to achieve drugs that have their positive effects as close to their maximum potency concentration while either eliminating side effects or bringing the material's concentration as far away from the side effects' maximum potency levels. [4]
The player produces the drugs using an assembly line approach with various equipment that can modify the concentration of the material, combine materials, rearrange the effects of a material to determine how effects combine when mixed, analyze materials to determine maximum potency levels, and finally prepare the material in pill form for delivery. This is done on an isometric view of building plant floorplan, with various ports along the edges that can be used to bring in materials or ship out completed drugs. Materials are transported via conveyor belts between the processing units. Added building space can be purchased with in-game funds. The player can click on processes or materials to evaluate their current state, thus giving them the ability to debug the production line. Once the player has produced a complete pill from specific materials for the first time and delivered it to an output port, they are given the opportunity to name the product. This product is then sold on the game's virtual market. The product is rated on a letter-grade based on the effectiveness and lack of side-effects as well as current market demand. The production lines operate in real-time—in that while the player can pause the game to arrange equipment within a production line, the game while running tracks the movement of each unit of material through the production line and only considered each unit as a product when it reaches the end of the production line.
In the larger game, the player must build up these drug production lines to maintain a profit and allow them to build additional lines. Scenarios in the game include competing companies that will also be releasing prescription drugs that will impact the profitability of the player's products. For example, if other companies have released a cold remedy drug, the market may be too saturated for a better cold remedy to succeed. The player can review what market demand there is for specific remedies to tailor productions toward those goals. In addition, the player can manage a research tree that enables more effective process equipment and other benefits to be built, and send out explorers to research on new possible ingredients to build from. The game includes a number of preset scenarios (such as reached a financial milestone after a number of years of operation) at various difficulty levels as well as the ability to create a custom open-ended game.
An expansion, "Marketing And Malpractice", was released on 26 April 2016. [5] This expansion added Executives as part of the company which can be used to market the drugs produced by the player's production lines, as well as to try to manipulate and corner the market. [6]
Big Pharma has a score of 72% on Metacritic, [7] and scored an 8/10 from IGN Spain. [8]
In economics, a network effect is the phenomenon by which the value or utility a user derives from a good or service depends on the number of users of compatible products. Network effects are typically positive feedback systems, resulting in users deriving more and more value from a product as more users join the same network. The adoption of a product by an additional user can be broken into two effects: an increase in the value to all other users and also the enhancement of other non-users' motivation for using the product.
Clarithromycin, sold under the brand name Biaxin among others, is an antibiotic used to treat various bacterial infections. This includes strep throat, pneumonia, skin infections, H. pylori infection, and Lyme disease, among others. Clarithromycin can be taken by mouth as a pill or liquid.
A generic drug is a pharmaceutical drug that contains the same chemical substance as a drug that was originally protected by chemical patents. Generic drugs are allowed for sale after the patents on the original drugs expire. Because the active chemical substance is the same, the medical profile of generics is equivalent in performance compared to their performance at the time when they were patented drugs. A generic drug has the same active pharmaceutical ingredient (API) as the original, but it may differ in some characteristics such as the manufacturing process, formulation, excipients, color, taste, and packaging.
A topical medication is a medication that is applied to a particular place on or in the body. Most often topical medication means application to body surfaces such as the skin or mucous membranes to treat ailments via a large range of classes including creams, foams, gels, lotions, and ointments. Many topical medications are epicutaneous, meaning that they are applied directly to the skin. Topical medications may also be inhalational, such as asthma medications, or applied to the surface of tissues other than the skin, such as eye drops applied to the conjunctiva, or ear drops placed in the ear, or medications applied to the surface of a tooth. The word topical derives from Greek τοπικόςtopikos, "of a place".
Bumetanide, sold under the brand name Bumex among others, is a medication used to treat swelling and high blood pressure. This includes swelling as a result of heart failure, liver failure, or kidney problems. It may work for swelling when other medications have not. For high blood pressure it is not a preferred treatment. It is taken by mouth, or by injection into a vein or muscle. Effects generally begin within an hour and lasts for about six hours.
The pharmaceutical industry is one of the leading industries in the People's Republic of China, covering synthetic chemicals and drugs, prepared Chinese medicines, medical devices, apparatus and instruments, hygiene materials, packing materials, and pharmaceutical machinery. China has the second-largest pharmaceutical market in the world as of 2017 which is worth US$110 billion. China accounts for 20% of the world's population but only a small fraction of the global drug market. China's changing health-care environment is designed to extend basic health insurance to a larger portion of the population and give individuals greater access to products and services. Following the period of change, the pharmaceutical industry is expected to continue its expansion.
In chemistry, fine chemicals are complex, single, pure chemical substances, produced in limited quantities in multipurpose plants by multistep batch chemical or biotechnological processes. They are described by exacting specifications, used for further processing within the chemical industry and sold for more than $10/kg. The class of fine chemicals is subdivided either on the basis of the added value, or the type of business transaction, namely standard or exclusive products.
Levobupivacaine (rINN) is a local anaesthetic drug indicated for minor and major surgical anaesthesia and pain management. It is a long-acting amide-type local anaesthetic that blocks nerve impulses by inhibiting sodium ion influx into the nerve cells. Levobupivacaine is the S-enantiomer of racemic bupivacaine and therefore similar in pharmacological effects. The drug typically starts taking effect within 15 minutes and can last up to 16 hours depending on factors such as site of administration and dosage.
Clocortolone (Cloderm) is a topical steroid. It is used in the form of an ester, clocortolone pivalate, and applied as a cream. It is used for the treatment of dermatitis and is considered a medium-strength corticosteroid. It is unusual among steroids in that it contains a chlorine atom and a fluorine atom.
A two-sided market, also called a two-sided network, is an intermediary economic platform having two distinct user groups that provide each other with network benefits. The organization that creates value primarily by enabling direct interactions between two distinct types of affiliated customers is called a multi-sided platform. This concept of two-sided markets has been mainly theorised by the French economists Jean Tirole and Jean-Charles Rochet and Americans Geoffrey G Parker and Marshall Van Alstyne.
In pharmacology, potency or biological potency is a measure of a drug's biological activity expressed in terms of the dose required to produce a pharmacological effect of given intensity. A highly potent drug evokes a given response at low concentrations, while a drug of lower potency evokes the same response only at higher concentrations. Higher potency does not necessarily mean greater effectiveness or more side effects.
Tapentadol, brand names Nucynta among others, is a centrally acting opioid analgesic of the benzenoid class with a dual mode of action as an agonist of the μ-opioid receptor and as a norepinephrine reuptake inhibitor (NRI). Analgesia occurs within 32 minutes of oral administration, and lasts for 4–6 hours.
A contract manufacturing organization (CMO), more recently referred to as a contract development and manufacturing organization (CDMO) to avoid the acronym confusion of Chief Medical Officer or Clinical Monitoring Organization in the pharma industry, is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing. This allows major pharmaceutical companies to outsource those aspects of the business, which can help with scalability or can allow the major company to focus on drug discovery and drug marketing instead.
Methylhexanamine is an indirect sympathomimetic drug invented and developed by Eli Lilly and Company and marketed as an inhaled nasal decongestant from 1948 until it was voluntarily withdrawn from the market in the 1980s.
Hash oil or cannabis oil is an oleoresin obtained by the extraction of cannabis or hashish. It is a cannabis concentrate containing many of its resins and terpenes – in particular, tetrahydrocannabinol (THC), cannabidiol (CBD), and other cannabinoids. Hash oil is usually consumed by smoking, vaporizing or eating. Preparations of hash oil may be solid or colloidal depending on both production method and temperature and are usually identified by their appearance or characteristics. Color most commonly ranges from transparent golden or light brown, to tan or black. There are various extraction methods, most involving a solvent, such as butane or ethanol.
The term environmental persistent pharmaceutical pollutants (EPPP) was first suggested in the nomination in 2010 of pharmaceuticals and environment as an emerging issue in a Strategic Approach to International Chemicals Management (SAICM) by the International Society of Doctors for the Environment (ISDE). The occurring problems from EPPPs are in parallel explained under environmental impact of pharmaceuticals and personal care products (PPCP). The European Union summarizes pharmaceutical residues with the potential of contamination of water and soil together with other micropollutants under "priority substances".
Naldemedine is a medication that is used for the treatment of opioid-induced constipation in adults with chronic non-cancer pain. It is a peripherally acting μ-opioid receptor antagonist and was developed by Shionogi. Clinical studies have found it to possess statistically significant effectiveness for these indications and to be generally well tolerated, with predominantly mild to moderate gastrointestinal side effects. Effects indicative of central opioid withdrawal or impact on the analgesic or miotic effects of co-administered opioids have only been observed in a small number of patients.
Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients is a book by the British physician and academic Ben Goldacre about the pharmaceutical industry, its relationship with the medical profession, and the extent to which it controls academic research into its own products. It was published in the UK in September 2012 by the Fourth Estate imprint of HarperCollins, and in the United States in February 2013 by Faber and Faber.
Positech Games is a video game developer based in the United Kingdom. The company was founded in 1997 and belongs to the former Lionhead Studios programmer Cliff Harris. The company has published a number of PC games. One of the most notable publications by Positech is the strategy game of policy shift Democracy. Positech is known for making complex simulation games.
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations active pharmaceutical ingredients and crop health science products, and also provides contract manufacturing services. It is a major producer of branded oncology medicines and hepatitis C drugs. The company specialises in producing complex medicines at affordable prices. In 2019, Natco launched its crop health sciences division.